These final results, along with a earlier report demonstrating that a small-molecule ACKR3 agonist CCX771 displays anxiolytic-like actions in mice,2 assist the notion of focusing on ACKR3 as a singular approach to modulate the opioid program, which could open up new therapeutic avenues for opioid-linked Problems. Importantly, these receptors https://marcelley950qhy6.snack-blog.com/profile